Illustrative GLP - 1 US adult adoption curve 10-year horizon 1 While usage for diabetes will continue to grow, the far larger growth driver will be users without a type 2 diabetes diagnosis who are focused on weight loss
During the first week, many people experience mild side effects as their body adjusts to the medication
Side effects are often more noticeable during the first weeks of treatment or after dose increases
Foods high in protein, fiber, and healthy fats can naturally support GLP-1 but putting that into practice consistently is where most people struggle
Semaglutide and tirzepatide studies show roughly two-thirds of lost weight returning within a year, with most regain in the first months and about one-third to 40% of the loss still held at one year. Retatrutide may produce greater regain pressure because its glucagon support for resting metabolism fades while appetite returns
Many gastrointestinal effects are transient, but severe, persistent, or worsening symptoms should be reported to a healthcare professional